p53RFP, a p53-inducible RING-finger protein, regulates the stability of p21WAF1
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The mechanisms by which p53 prevents development of cancer are much more complicated than previously thought. Under normal conditions, p53 is involved in cell-cycle arrest, Q1apoptosis, DNA repair, and inhibition of angiogenesis; it also promotes degradation of proteins through transcriptional regulation of certain target genes. Here we report the isolation of a novel transcriptional target of p53, designated p53RFP (p53-inducible RING-finger protein), whose product has E3 ubiquitin ligase activity. Its expression was negatively correlated to that of p21(WAF1) protein; p53RFP is likely to play a role in the regulation of this protein, probably through interaction with, and ubiquitination of, p21(WAF1). p53RFP appears to represent the second known example, the first being MDM2, of an E3 ubiquitin ligase as a p53 target. Our results further suggest that p53 might regulate the stability of p21(WAF1) through transcriptional regulation of p53RFP, and this feature may represent a novel mechanism for a p53-dependent cell-cycle checkpoint.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, PGM levels were unaffected by either Mdm2 or p53RFP, two ubiquitin ligases that are known to be regulated by p53 (refs. 35, 36; data not shown).”
From Glycolytic Enzymes Can Modulate Cellular Life Span (2005) · cites this paper as [35]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“GADD45 and a ribonucleotide reductase, p53R2, are involved in DNA repair, whereas p53AIP1, BAX, NOXA, KILLER/DR5, Fas, PIDD and are p53 targets that play significant roles in the p53-inducible apoptotic pathway (Vogelstein et al., 2000).”
BackgroundThe p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651 · cited 1×
“Among the p53-target genes identified so far, p21WAF1, an inhibitor of cyclin-dependent kinase, is a well-known p53 mediator in arrest of the cell cycle at G1 (Harper et al., 1993).”
BackgroundDefinition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985
Joazeiro, C. A. P., & Weissman, A. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00077-5 · Cited by 1,249 · cited 1×
“…in the ubiquitination pathway, as many of them have E3 ligase activity or function as essential cofactors of the E3 complex (Jackson et al., 2000; Joazeiro and Weissman, 2000). p53RFP might be the second known example of an E3 ubiquitin ligase as a p53 target (the first being MDM2, a negative…”
BackgroundOda, K., Arakawa, H., Tanaka, T., Matsuda, K., Tanikawa, C., Mori, T., Nishimori, H., Tamai, K., Tokino, T., Nakamura, Y., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00073-8 · Cited by 1,172 · cited 1×
“…a p53-dependent manner as early as 12 h after infection (Figure 1a), but its induction revealed a 6 h delay, compared to that of p21WAF1, suggesting a distinct regulation by the modified p53 between the transcript and p21WAF1 as previously reported in another p53 target, p53AIP1 (Oda et al., 2000).”
ResultSelf-citationMdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Zhang, Y., Gao, J., Chung, K. K. K., Huang, H., Dawson, V. L., & Dawson, T. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.240347797 · Cited by 982
The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases
Jackson, P. K., Eldridge, A. G., Freed, E., Furstenthal, L., Hsu, J. Y., Kaiser, B. K., & Reimann, J. D. R. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01834-1 · Cited by 634
Analysis of p53-regulated gene expression patterns using oligonucleotide arrays
Zhao, R., Gish, K., Murphy, M., Yin, Y., Notterman, D., Hoffman, W. H., Tom, E., Mack, D. H., & Levine, A. J. (2000) · Genes & Development · doi:10.1101/gad.14.8.981 · Cited by 634
Zhang, Z.-X., Yang, L., Young, K. J., DuTemple, B., & Zhang, L. (2000) · Nature Medicine · doi:10.1038/77513 · Cited by 459 · cited 1×
“Parkin, another molecule with a RING-IBR-RING domain, functions as an E3ubiquitin ligase that binds an E2-ubiquitin-conjugating enzyme, UbcH8, to promote degradation of the synaptic vesicle-associated protein, CDCrel-1 (Zhang et al., 2000).”
BackgroundIdentification and classification of p53-regulated genes
Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., & Vogelstein, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14517 · Cited by 452
Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21 CIP1/WAF1 and cyclin D proteins
Yu, Z.-K., Gervais, J. L. M., & Zhang, H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.19.11324 · Cited by 411
Ubiquitin Enters the New Millennium
Pickart, C. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00347-1 · Cited by 393
Proteasomal Turnover of p21Cip1 Does Not Require p21Cip1 Ubiquitination
Sheaff, R. J., Singer, J. D., Swanger, J., Smitherman, M., Roberts, J. M., & Clurman, B. E. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80435-9 · Cited by 382
Bordallo, J., Plemper, R. K., Finger, A., & Wolf, D. H. (1998) · Molecular Biology of the Cell · doi:10.1091/mbc.9.1.209 · Cited by 374
p53DINP1, a p53-Inducible Gene, Regulates p53-Dependent Apoptosis
Okamura, S., Arakawa, H., Tanaka, T., Nakanishi, H., Ng, C. C., Taya, Y., Monden, M., & Nakamura, Y. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00284-2 · Cited by 351
Self-citationTouitou, R. (2001) · The EMBO Journal · doi:10.1093/emboj/20.10.2367 · Cited by 236
Proteasome-Dependent Regulation of p21WAF1/CIP1Expression
Blagosklonny, M. V., Wu, G. S., Omura, S., & El-Deiry, W. S. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1546 · Cited by 221 · cited 1×
“In mammalian cells, p21WAF1 is an unstable and short-lived protein that exhibits ubiquitination in vivo and proteasome-dependent turnover (Blagosklonny et al., 1996: Fukuchi et al., 1999).”
BackgroundClinical aspects of altered glycosylation of glycoproteins in cancer
Orntoft, T. F., & Vestergaard, E. M. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990201)20:2<362::aid-elps362>3.0.co;2-v · Cited by 205
The role of p53-target genes in human cancer
Tokino, T., & Nakamura, Y. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00051-7 · Cited by 174
Self-citationThe p53 Family Member Genes Are Involved in the Notch Signal Pathway
Sasaki, Y., Ishida, S., Morimoto, I., Yamashita, T., Kojima, T., Kihara, C., Tanaka, T., Imai, K., Nakamura, Y., & Tokino, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108080200 · Cited by 172
Self-citationStrategies for manipulating the p53 pathway in the treatment of human cancer
Hupp, T. R., Lane, D. P., & Ball, K. L. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520001 · Cited by 148
Interaction with cyclin-dependent kinases and PCNA modulates proteasome-dependent degradation of p21
Cayrol, C., & Ducommun, B. (1998) · Oncogene · doi:10.1038/sj.onc.1202189 · Cited by 147 · cited 1×
“Since several studies indicated the presence of several forms of p21WAF1 protein that are modified by phosphorylation and ubiquitination (Cayrol and Ducommun, 1998; Rousseau et al., 1999), we speculated that p53RFP might regulate some form(s) of p21WAF1 that has different functions from other forms.”
BackgroundRousseau, D. L., Cannella, D., Boulaire, J., FITZGERALD, P. J., Fotedar, A., & Fotedar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202681 · Cited by 133
Rousseau, D. L., Cannella, D., Boulaire, J., FITZGERALD, P. J., Fotedar, A., & Fotedar, R. (1999) · Oncogene · doi:10.1038/sj.onc.1202686 · Cited by 101 · cited 1×
“Since several studies indicated the presence of several forms of p21WAF1 protein that are modified by phosphorylation and ubiquitination (Cayrol and Ducommun, 1998; Rousseau et al., 1999), we speculated that p53RFP might regulate some form(s) of p21WAF1 that has different functions from other forms.”
BackgroundMatsuda, N., Suzuki, T., Tanaka, K., & Nakano, A. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.10.1949 · Cited by 97
The measurement of ubiquitin and ubiquitinated proteins
Mimnaugh, E. G., Bonvini, P., & Neckers, L. (1999) · Electrophoresis · doi:10.1002/(sici)1522-2683(19990201)20:2<418::aid-elps418>3.0.co;2-n · Cited by 87 · cited 1×
“A discrete laddering was observed in the banding pattern, indicating that p53RFP was polyubiquitinated (Mimnaugh et al., 1999) (Figure 3a,b).”
BackgroundFukuchi, K., Maruyama, H., Takagi, Y., & Gomi, K. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00081-6 · Cited by 20
Research works printed but not linked: 1
- Hupp TR, Lane DP and Ball KL . (2000). Biochem. J., 352(Part 1), 1–17 · doi:10.1042/bj3520001 · Paper page
Cited by
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921
Mutual exclusivity analysis identifies oncogenic network modules
Ciriello, G., Cerami, E., Sander, C., & Schultz, N. (2012) · Genome Research · doi:10.1101/gr.125567.111 · Cited by 675
“It negatively regulates p21 (CDKN1A) which itself directly inhibits several cyclin-dependent kinases, including CCNE1 (Ng et al. 2003).”
BackgroundGlycolytic Enzymes Can Modulate Cellular Life Span
Kondoh, H., Lleonart, M. E., Gil, J., Wang, J., Degan, P., Peters, G., Martinez, D., Carnero, A., & Beach, D. (2005) · Cancer Research · doi:10.1158/0008-5472.177.65.1 · Cited by 647
Self-citationRBR E3 ubiquitin ligases: new structures, new insights, new questions
Spratt, D. E., Walden, H., & Shaw, G. S. (2014) · Biochemical Journal · doi:10.1042/bj20140006 · Cited by 315
Ubiquitylation and proteasomal degradation of the p21Cip1, p27Kip1and p57Kip2CDK inhibitors
Lu, Z., & Hunter, T. (2010) · Cell Cycle · doi:10.4161/cc.9.12.11988 · Cited by 224
Metadata
- Authors
- Ng, C.-C., Arakawa, H., Fukuda, S., Kondoh, H., & Nakamura, Y.
- Affiliations
- Institute of Medical Science, The University of Tokyo (JP)
- The University of Osaka (JP)
- Corresponding author
- Nakamura, Yusuke
- Venue
- Oncogene
- Published
- 2003-07-10
- Volume
- 22
- Issue
- 28
- Pages
- 4449-4458
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2012650432
- Cited by
- 54
- References
- 27
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 4 · 2020: 1 · 2019: 4 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 2
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- p53, p21, protein stability, E3 ubiquitin ligase, ubiquitination, transcription factor target genes, cell cycle checkpoints, tumor suppressor regulation, MDM2
- MeSH terms
- Amino Acid Sequence, Humans, Ligases, Molecular Sequence Data, RNA, Messenger, Transcription, Genetic, Tumor Cells, Cultured, Tumor Suppressor Protein p53, Cyclins, Zinc Fingers, Ubiquitin-Protein Ligases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.